Imaging3, Inc. Announces Completion of Outstanding Form 10-Q Quarterly Filings
Burbank, CA, January 23, 2016 --(PR.com)-- Imaging3™, Inc. (OTCBB: IMGGQ) announces today that it has finalized and published 2012, 2013, 2014 and 2015 Quarterly results. The finalizing of these financials was completed by Rose, Snyder & Jacobs LLP located in Encino, CA. Imaging3 is now current on all of its required Form 10-Q and Form 10-K financial statements and expects to file its annual report on Form 10-K for 2015 by March 31, 2016.
Dane Medley, Imaging3’s Chairman and CEO, stated, “The completion of our financial statements has moved the company one step closer toward becoming public again. It has taken a collaboration of many individuals and business partners working diligently towards the same objectives. We are continuing to pursue several opportunities that we hope will increase our revenues and bring value to our investors.”
Mr. Medley also stated, “We will now interview market makers to assist us in filing our Form 211 with FINRA. With continued hard work, we are hopeful that Imaging3 will be able to reemerge as a public company. We will have more to announce soon.”
Imaging3 will provide ongoing updates in the form of filings and press releases, all of which can be found on our website, www.imaging3.com, under the news tab at the top of the page.
About Imaging3
Imaging3, Inc., founded in 1993, has developed a medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company’s website at http://www.imaging3.com for more information
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, technological obsolescence, competition from other medical instrument(s) and imaging companies, lack of capital, unexpected costs, failure or delay of FDA approval, failure to obtain a trading symbol from FINRA or be approved to trade as a public company, failure to consummate desired business combinations or transactions, delays or adverse rulings relating to its pending Chapter 11 bankruptcy action, absence of revenue, the impact on the national and local economies resulting from an economic recession or terrorist actions, and U.S. actions subsequently; unavailability of financing for the Company or its customers, product malfunction, potential product liability claims, and other factors detailed in reports filed by the Company. Imaging3 cannot assure that it will obtain regulatory approval for its products, successfully complete the Chapter 11 bankruptcy process, obtain a trading symbol from FINRA, or reemerge as a public company.
Contact:
Imaging3, Inc.
Investor Relations
800-900-9729
Dane Medley, Imaging3’s Chairman and CEO, stated, “The completion of our financial statements has moved the company one step closer toward becoming public again. It has taken a collaboration of many individuals and business partners working diligently towards the same objectives. We are continuing to pursue several opportunities that we hope will increase our revenues and bring value to our investors.”
Mr. Medley also stated, “We will now interview market makers to assist us in filing our Form 211 with FINRA. With continued hard work, we are hopeful that Imaging3 will be able to reemerge as a public company. We will have more to announce soon.”
Imaging3 will provide ongoing updates in the form of filings and press releases, all of which can be found on our website, www.imaging3.com, under the news tab at the top of the page.
About Imaging3
Imaging3, Inc., founded in 1993, has developed a medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company’s website at http://www.imaging3.com for more information
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, technological obsolescence, competition from other medical instrument(s) and imaging companies, lack of capital, unexpected costs, failure or delay of FDA approval, failure to obtain a trading symbol from FINRA or be approved to trade as a public company, failure to consummate desired business combinations or transactions, delays or adverse rulings relating to its pending Chapter 11 bankruptcy action, absence of revenue, the impact on the national and local economies resulting from an economic recession or terrorist actions, and U.S. actions subsequently; unavailability of financing for the Company or its customers, product malfunction, potential product liability claims, and other factors detailed in reports filed by the Company. Imaging3 cannot assure that it will obtain regulatory approval for its products, successfully complete the Chapter 11 bankruptcy process, obtain a trading symbol from FINRA, or reemerge as a public company.
Contact:
Imaging3, Inc.
Investor Relations
800-900-9729
Contact
Imaging3
Dane Medley
800-900-9729
www.imaging3.com
Dane Medley
800-900-9729
www.imaging3.com
Contact
Categories